Bavarian Nordic Publishes Annual Report 2024
Audited results confirm full-year revenue of DKK 5,716 million and EBITDA of DKK 1,603 million. Two new early-stage…
Storage Beyond Boundaries: Exascend at Embedded World 2025
Exascend, a global leader in advanced storage and memory solutions, is excited to announce its participation in Embedded…
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya preven…
ViGeneron Announces FDA Rare Pediatric Disease Designation for VG901 and DSMB Approval to Advance Dose Escalation in Phase 1b Retinitis Pigmentosa Trial
. VG901 is the first-in-class and only clinical-stage therapy designed to deliver the functional CNGA1 gene intravitr…
End-to-end warehouse automation with SAP EWM in the focus of LogiPlus
. Hall: 4, Stand number: C49 Under the motto ‘Let's Rock the Stock’, LogiPlus will once again be demonstrating how comp…
NETZSCH Makes Children Smile
Christmas: the celebration of love, time with family and friends, quiet holidays, presents under the Christmas tree. Wha…
Enhancing Gift Wrapping Traditions
Gift wrapping is a cherished tradition, transforming the act of giving into an experience full of anticipation and joy.…
ATIX Christmas Raffle
The Christmas season is just around the corner and we have prepared something special for you: our ATIX Christmas raffle…
The Payments Group partners with HubPeople to bring cash payments to another 100 million users
The Payments Group, the newly formed operating unit under the umbrella of The Payments Group Holding, has announced its…
AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9
Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidia…